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Lung cancer is the most common malignanc xx orldxx ide and is the
leading cause of cancer death in North America and in Hawan. It is
estimated that 90% of lung cancer deaths in the L.S. are caused by
smoking. Risk has been shoxx n to increase in relation to both
smoking intensity and duration, and a person xx ho smoked one pack
per day for So years is estinmted to have a lung cancer risk ten— to
txx cnn—fold greater than that of a life—long non—smoker. Smoking
cessation leads to a reduction in the risk of lung cancer. hut not
significantly before the fifth sear and risk. possihlx. flC\ er quite
returns to the background level ofa life—long non-smoker. The major
increase in cicarette consumption starting in the 19 lOs has resulted
in a sharp rise in lune cancer occunence between the I 930s and
I 980s. Rates in Hawaii have noxx peaked in males but are still
increasing in females. Even though smoking rates have decreased.
this disease will remain an important source of mortality in the future
due to the large number of former smokers in our population. In the
past flfty years, we have also seen a shift in the pathologic presen
tation of lung cancer in Hawaii. as in other parts of the US. The
frequency of adenocarcinoma has markedly increased, whereas that
of squamous cell carcinoma has proportionally decreased, presum
ably as a result of changes in cigarette composition and smoking
behavior, Survival from lung cancer has remained extremely poor
with a five-year survival rate of 12-15%.
Incidence rates for lung cancer show marked differences among
ethnic groups in Hawaii. with the rates for Hawaiians and Cauca
sians being two- to three-fold higher than those forthe Asian groups.
The etiologic research undertaken on this malignancy at the Cancer
Research Center of Hawaii has been aimed at elucidating these
ethnic differences, with the goal of advancing our understanding of
the disease, Because there seemed to he a poor correlation between
lifelong smoking patterns and lung cancer incidence among the
main ethnic groups in our population, efforts first focused on
exploring other possible risk factors and, in particular. diet. Faculty
of the Center’s Epidemiology Program were among the first to
report that intake of lipids may increase lung cancer risk and that a
variety of constituents in fruits and vegetables may he protec lix e.
At a time xx hen most studies focused on beta-carotene onl\. we
showed that additional carotenoids (especial lv. lutein and alpha—
carotene may decrease risk: More recently. xx e also shoxx ed that
certain flax onoids tquercetin in onions and apples. and naringin
from grapefruit) may also be protectix c.’ Because recent large
clinical trials testine the ability of beta—carotene to prevent lung
cancer hax e shown no beneficial effect and cx en a detrimental
effect in high risk ,mokers;i. the potential preveiltix e ettects of other
plant constituents (“phytochemicals”) are currently receiving re
newed research interest.
The detailed information collected from a large number of pa
tients in Hawaii allowed us to examine the relationship between
smoking and lung cancer in the main ethnic groups. After taking into
account patterns of smoking (intensity, duration, txpe of cigarettes,
depth of inhalation, etc.), we found that the overall lung cancer risk
associated with cigarette smoking was 1 20 greater for Hawaiians
and 50% greater for Caucasians than for Japanese. As a possible
explanation for these diflerence. we turned our attention to the
possihilit that the ability to activate or detoxif carcinogens trom
tobacco smoke varies among ethnic gioup. Many chemical car
cinogens need first to be transformed into reactix e intermediates that
are capable of binding to DNA. potentially starting the carcinogenic
process. Considerable variation exists among individuals in the
activity of the enzymes responsible for the activation and detoxifi
cation of tobacco carcinogens e.g.. cytochrome P450 en/v nies,
glutathione—S—transferases At least part of this variability is often
due to minor inherited genetic variation e.g.. single nucleotide
polymorphism SNPs i that affects the transcription of the gene or
function of the protein. Thus, we have been investigating whether
cenetic variants in the genes coding for these enzymes occur with
different frequencies among the ethnic group.whetlier they can be
shown to affect enzyme activity and whether they are associated
with risk of lung cancer. We are also studying the effects of various
dietary factors on these enzymatic pathxx ays in relation to lung
cancer risk.
For example. we recently showed that a polymorphism in the
CYPlAlgene was directly’ associated with lung squamous cell
carcinoma and that a polymorphism in the CYP2E I gene was
inversely associated with lung adenocarcinoma. pointing to differ
ent etiologies for these tumors. We also showed that the frequencies
of these polymorphisms vary markedly among ethnic groups and
that they both result in a change in enzyme activity.’3The inducihil
ity of cytochrome P45OlAl (which bioactivates povlcyclic hydro
carbons) was found to be increased in subjects with the variant
CYPIAI allele. The activity of cytochrome P4502E1 (capable of
activating nitrosamines) was reduced for subjects with the CYP2EJ
variant allele. Examining the detailed dietary information collected
on the subjects, we found that the protective effect of onion intake
against lung cancer differed according to the CYPIA I genotype of
the subjects, suggesting that the known inhibiting effect of the
flavonoid quercetin (present in large quantities in onions) on CYPI Al
may be an important protective mechanism. Studies using various
hiomarkers of exposure, genetic susceptibility and early biological
effects have been initiated to confirm these relationships. In particu
lar, we are currently recruiting smokers for feeding studies in xvhich
the effects of specific vegetables and fruits on carcinogen activation
are being tested.
Other polymorphisms found to he associated with lung cancer in
our population include variants in “metabolic genes” ( glutathionc—
5—transferase. mveloperoxidase. \ADPH—qui none—oxidoreductase,
X—oxoguanine glvcosvlaset and oncogenes 1 iI-ra.s I. suggesting a
role for specific aeents and/or mechanisms in the etio1og of this
disease. Hawaiis multiethnic population is a unique resource
such studies as the ethnic groups hax c retained different cancer risk
patterns and cifferent frequencies for many of the’e genetic poi —
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morphisms. This allows for valuable comparisons and a gain in
statistical power.
Each year. lung cancer kills about one million individuals world
wide. including about 4(f) in Rass au Avoidance ot all tobacco
smoking is a clear priority in preventing the disease and public
health strategies have been largel\ successful in gradually changing
.mokiny’ behaviors. However, additional approaches are needed for
Ntronglv addicted smokers who are unable to quit. and for cx
smokers since they remain for many years at significantly increased
risk. Progress in our understanding of the biological processes
involved in nicotine addiction and lung carcinogenesis is leading to
the identification of genetic susceptibility markers for smoking and!
or lung cancer, as well as markers of early disease. Such new
markers might allow the identihcation of high risk individuals for
.pecificall designed interventions. Moreover, a number of nutri
tional or pharmaceutical agents are known to block carcinogen
acti ation, enhance detoxification or inhibit downstream carcino
genic events in e’1perimental models. They ma lead to nutritional
or chemopreention approaches that may be useful for the preven
tion of lung cancer and the many other malignancies that have been
related to smoking. Our goal is to continue to contribute new
knowledge in these areas. However, further tobacco control and
improved cessation strategies are likely to remain the key compo
nent in the prevention of lung cancer.
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Mammograms...
Not just once, but
for a lifetime
Medicare helps pay for
yearly mammograms.
For Medicare information,
call 1-800-638-6833.
For information on breast cancer
and mammograms. call the
National Cancer institute’s
Cancer Infrmation Service at
1-800-4-CANCER (1-800-422-6237).
Persons with TTY equipment, dial
1-800-332-8615.
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